中国药物经济学
中國藥物經濟學
중국약물경제학
China Journal of Pharmaceutical Economics
2015年
10期
40-41
,共2页
厄贝沙坦%酒石酸美托洛尔片%老年%心房颤动%临床疗效
阨貝沙坦%酒石痠美託洛爾片%老年%心房顫動%臨床療效
액패사탄%주석산미탁락이편%노년%심방전동%림상료효
Irbesartan%Betaloc%The elderly%Atrial fibrilation%Clinical curative effect
目的:探讨厄贝沙坦联合酒石酸美托洛尔片治疗老年心房颤动患者的临床疗效。方法选取2014年1—12月在河南省平舆县人民医院就诊的老年心房颤动患者资料84例,按随机数字表法将其分为试验组和对照组,各42例。对照组患者口服酒石酸美托洛尔片,试验组患者在对照组基础上口服厄贝沙坦,比较两组患者的临床疗效、心房颤动发作次数及持续时间。结果试验组患者总有效率为90.5%,明显高于对照组的73.8%,差异有统计学意义(P<0.05);试验组患者心房颤动发作次数明显少于对照组,持续时间明显短于对照组,差异均有统计学意义(均P<0.05)。结论厄贝沙坦联合酒石酸美托洛尔片治疗老年心房颤动临床疗效明显,可避免或减少心房颤动发作。
目的:探討阨貝沙坦聯閤酒石痠美託洛爾片治療老年心房顫動患者的臨床療效。方法選取2014年1—12月在河南省平輿縣人民醫院就診的老年心房顫動患者資料84例,按隨機數字錶法將其分為試驗組和對照組,各42例。對照組患者口服酒石痠美託洛爾片,試驗組患者在對照組基礎上口服阨貝沙坦,比較兩組患者的臨床療效、心房顫動髮作次數及持續時間。結果試驗組患者總有效率為90.5%,明顯高于對照組的73.8%,差異有統計學意義(P<0.05);試驗組患者心房顫動髮作次數明顯少于對照組,持續時間明顯短于對照組,差異均有統計學意義(均P<0.05)。結論阨貝沙坦聯閤酒石痠美託洛爾片治療老年心房顫動臨床療效明顯,可避免或減少心房顫動髮作。
목적:탐토액패사탄연합주석산미탁락이편치료노년심방전동환자적림상료효。방법선취2014년1—12월재하남성평여현인민의원취진적노년심방전동환자자료84례,안수궤수자표법장기분위시험조화대조조,각42례。대조조환자구복주석산미탁락이편,시험조환자재대조조기출상구복액패사탄,비교량조환자적림상료효、심방전동발작차수급지속시간。결과시험조환자총유효솔위90.5%,명현고우대조조적73.8%,차이유통계학의의(P<0.05);시험조환자심방전동발작차수명현소우대조조,지속시간명현단우대조조,차이균유통계학의의(균P<0.05)。결론액패사탄연합주석산미탁락이편치료노년심방전동림상료효명현,가피면혹감소심방전동발작。
Objective To evaluate the clinical efficacy of irbesartan combined with metoprolol in treatment of elderly patients with atrial fibrilation.Methods From January 2014 to December 2014,84 patients with atrial fibrilation were randomly divided into study group and control group by random digits table method,42 cases in each group.Control group was treated with oral times his Le Ke,the patients in the treatment group in the control group on the basis of oral administration of irbesartan,compared two groups of patients with clinical curative effect,atrial fibrilation attack frequency and duration.Results Patients in the study group,the total efficiency was 90.5%,signif- icantly higher than that of 73.8% in the control group,the difference was statisticaly significant (P<0.05);study group of patients with atrial fibrilation episodes was significantly less than that of the control group,duration was significantly shorter than that of the control group,the differences were statisticaly significant(P<0.05).Conclusion Irbesartan combined with metoprolol in treatment of elderly patients with atrial fibrilation clinical curative effect,can avoid or reduce the onset of atrial fibrilation.